Related Experiment Video
Updated: Nov 14, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Segmental overgrowth and aneurysms due to mosaic PDGFRB p.(Tyr562Cys)
Jirat Chenbhanich1, Yan Hu2, Steven Hetts3
1Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, California, USA.
Abstract:
Activating variants in the platelet-derived growth factor receptor β gene (PDGFRB) have been associated with Kosaki overgrowth syndrome, infantile myofibromatosis, and Penttinen premature aging syndrome. A recently described phenotype with fusiform aneurysm has been associated with mosaic PDGFRB c.1685A > G p.(Tyr562Cys) variant. Few reports however have examined the vascular phenotypes and mosaic effects of PDGFRB variants. We describe clinical characteristics of two patients with a recurrent mosaic PDGFRB p.(Tyr562Cys) variant identified via next-generation sequencing-based genetic testing. We observed intracranial fusiform aneurysm in one patient and found an additional eight patients with aneurysms and phenotypes associated with PDGFRB-activating variants through literature search. The conditions caused by PDGFRB-activating variants share overlapping features including overgrowth, premature aged skin, and vascular malformations including aneurysms. Aneurysms are progressive and can result in morbidities and mortalities in the absence of successful intervention. Germline and/or somatic testing for PDGFRB gene should be obtained when PDGFRB activating variant-related phenotypes are present. Whole-body imaging of the arterial tree and echocardiography are recommended after diagnosis. Repeating the imaging study within a 6- to 12-month period after detection is reasonable. Finally, further evaluation for the effectiveness and safety profile of kinase inhibitors in this patient population is warranted.
Insights
Activating platelet-derived growth factor receptor β (PDGFRB) variants cause overgrowth and premature aging syndromes. This study highlights PDGFRB variants in patients with aneurysms, emphasizing the need for genetic testing and vascular imaging.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Developmental Biology
Background:
- Activating variants in the platelet-derived growth factor receptor β (PDGFRB) gene are linked to Kosaki overgrowth syndrome, infantile myofibromatosis, and Penttinen premature aging syndrome.
- A specific mosaic PDGFRB variant (c.1685A>G p.(Tyr562Cys)) has been associated with a phenotype including fusiform aneurysms.
- Limited research exists on the vascular manifestations and mosaicism associated with PDGFRB variants.
Purpose of the Study:
- To describe the clinical features of two patients with a recurrent mosaic PDGFRB p.(Tyr562Cys) variant.
- To investigate the association between PDGFRB-activating variants and vascular phenotypes, particularly aneurysms.
- To review existing literature for similar cases and consolidate knowledge on PDGFRB-related conditions.
Main Methods:
- Next-generation sequencing-based genetic testing was used to identify the PDGFRB variant in two patients.
- Clinical characteristics of the patients were documented.
- A literature search was conducted to identify additional patients with aneurysms and phenotypes related to PDGFRB-activating variants.
Main Results:
- Two patients with a recurrent mosaic PDGFRB p.(Tyr562Cys) variant were identified, with one presenting intracranial fusiform aneurysm.
- A literature review revealed eight additional patients with aneurysms and phenotypes consistent with PDGFRB-activating variants.
- Conditions associated with PDGFRB-activating variants share overlapping features such as overgrowth, premature aging of the skin, and vascular malformations including aneurysms.
Conclusions:
- PDGFRB-activating variants are associated with a spectrum of conditions including overgrowth, premature aging, and progressive vascular malformations like aneurysms.
- Germline and/or somatic PDGFRB gene testing is recommended for individuals presenting with related phenotypes.
- Comprehensive vascular imaging (arterial tree and echocardiography) and follow-up imaging are crucial for managing these progressive conditions.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
09:45Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
Related Concept Videos
Abnormal Proliferation
Aneurysm I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Valve Prolapse I: Introduction
The Ras Gene
Ras is a...
Aneurysm II: Clinical Manifestations and Diagnostic Studies